Stay updated on Empagliflozin in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin in Heart Failure Clinical Trial page.

Latest updates to the Empagliflozin in Heart Failure Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision metadata was updated from v3.6.2 to v3.6.3. This reflects a new site revision label and does not modify the displayed study details.SummaryDifference0.1%

- Check17 days agoChange DetectedFooter revision updated from v3.6.0 to v3.6.2. This indicates a minor site update and does not affect the study details or data presented.SummaryDifference0.1%

- Check31 days agoChange DetectedNew help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the study is now listed as No longer looking for participants. The Intervention section label was updated from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision note was updated to Revision: v3.6.0 (removing v3.5.5).SummaryDifference0.5%

- Check40 days agoChange DetectedThe page now displays a new revision number, updating the platform version from v3.5.4 to v3.5.5. This change is administrative and does not alter the study details shown.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a minor update to the page’s metadata and not altering the study details or content. No data or content changes are evident.SummaryDifference0.1%

- Check83 days agoChange DetectedThe ClinicalTrials.gov page footer version was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a modification to the study information shown.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin in Heart Failure Clinical Trial page.